Best Hematology Specialists in Staten Island, NY

Marcel Odaimi MD is a medical oncologist and hematologist at Staten Island University Hospital where he treats all types of cancer using tailored combinations of chemotherapy immunotherapy and targeted therapy His focus is managing gastrointestinal cancers including esophageal stomach and pancreatic malignancies in addition to brain and spinal cord tumors In addition he treats benign hematologic conditions such as anemia and blood clotting disorders and has an interest in blood cancers including lymphoma and multiple myeloma With more than 30 years of experience in the field he values providing his patients with compassionate personalized care grounded in the latest evidence based medicine I take the time to talk with patients about their diagnosis and treatment options including the latest innovations in medical oncology he says I also listen to their feedback and concerns and create a comforting environment for their care Dr Odaimi earned his medical degree from the American University of Beirut and received his internal medicine residency training at Staten Island University Hospital He went on to complete his fellowship in medical oncology at the University of Texas MD Anderson Cancer Center one of the top cancer institutes in the United States At Northwell Health Dr Odaimi provides a multidisciplinary approach to patient care He works with pathologists radiologists surgical oncologists radiation oncologists and supportive care specialists to create treatment plans for his patients We work closely together and all of our services for patients are under one roof he says Dr Odaimi is an assistant professor at the Donald and Barbara Zucker School of Medicine at Hofstra Northwell His professional memberships include the American Society of Clinical Oncology the American Medical Association and the Richmond County Medical Society He has been a Castle Connolly Top Doctor New York Metro Area digital guide for the last seven years One of the best parts of Dr Odaimi s job is being able to problem solve for the benefit of his patients Every patient is unique so every treatment plan and each workday is different he says He also views his job as a vocation I feel privileged that I get to develop a close bond with patients that you don t often see in other professions

Dr. Pierro is a board-certified pediatric hematologist/oncologist. She completed medical school at New York College of Osteopathic Medicine followed by residency and chief residency in Pediatrics here at Staten Island University Hospital. She then completed a fellowship in Pediatric Hematology/Oncology at NYU Langone Health and remained on their faculty before returning to Staten Island University Hospital. Her research in relapsed acute lymphoblastic leukemia was supported by Young Investigator grants from both the St. Baldrick s and Alex s Lemonade Stand Foundations. She is an active member of the American Society of Hematology, the American Society of Oncology, and the American Society of Pediatric Hematology Oncology as well as a mentee in the Young Investigators Program in the Children s Oncology Group.Dr. Pierro provides clinical evaluations and treatments for a wide variety of hematologic and oncologic problems in patients spanning the newborn period through 21 years of age. She specializes in the care of patients with leukemia, lymphoma and solid tumors as well as a variety of non-cancerous blood disorders such as anemia, low white blood cell counts, low platelet counts, bleeding disorders, clotting disorders and sickle cell disease.As a native Staten Islander, Dr. Pierro is particularly proud to serve her community. She appreciates the hardships families face when their child requires treatment for cancer or a serious blood disorder and strives to provide quality, patient- and family- focused care close to home.

Terenig Terjanian, MD, is a hematologist and medical oncologist at Northwell Health, and an assistant professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Growing up in Lebanon, Dr. Terjanians early love for biology and chemistry set him on the path toward medicine. After attending St. Josephs University, he did a residency in pathology at American University of Beirut Medical Center, and one in internal medicine at Staten Island University Hospital. He then did fellowships in hematology and oncology at NYU Grossman School of Medicine and University of Texas MD Anderson Cancer Center. Although he initially specialized in pathology, Dr. Terjanian chose cancer care as a main focus after coming to the United States in 1981. ``The number one thing I want patients to know is that I'll listen to them,`` he says. ``I try to go over every aspect of their disease slowly, explain why we order the tests we do, and have them be completely aware of all the steps,`` he says, adding that he often gives patients his cell number, because he knows concerns can come up anytime. ``I think of what I would want as a patient, and it would be a doctor who really cares.`` Dr. Terjanian is deeply interested in clinical research. He has been the principal investigator on several protocols, including those of the National Surgical Adjuvant Breast and Bowel Project at Staten Island University Hospital, and has published multiple peer-reviewed papers and abstracts and presented at international meetings. He also runs the research committee for medical residents interested in hematology-oncology, and for fellows in that specialty. He's a member of the system-wide Institutional Review Board, a group that ensures clinical trials are done ethically and safely. In addition to participation in weekly tumor board meetings, and frequently providing lectures for interns and residents, Dr. Terjanian still enjoys the chemistry and biology that drew him to medicine from the start, especially since the science in oncology changes so rapidly which leads to improved patient outcomes. ``Every day, there is something new happening in cancer diagnosis and treatment, and it's exciting to see that progress,`` he says. ``Patients are living longer, they're experiencing better quality of life with targeted therapy or immunotherapy. Its immensely satisfying to see how far we've come.``